Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Super Mirco (SMCI) To Contact Him Directly To Discuss Their Options If you purchased or acquired Super Micro securities between April 30, 2024 and March 19, 2026 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- What’s Happeni ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Beta Bionics To Contact Him Directly To Discuss Their OptionsIf you suffered significant losses in Beta Bionics stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - March 26, 2026) - Faruqi ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Wealthfront To Contact Him Directly To Discuss Their Options If you suffered significant losses in Wealthfront stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, L ...

Berger Montague PC Investigating Potential Claims on Behalf of Investors in Northern Dynasty Minerals Ltd. (NYSE: NAK) Accessibility StatementSkip Navigation PHILADELPHIA, March 24, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PCannounces an investigation into potential claims on behalf of investors in Northern Dynasty Minerals Ltd. (NYSE: NAK) ("Northern Dynasty" or the "Company"). The investigation is focused on whether Northern Dynasty and members of senior management violated the f ...

Core Viewpoint - Insulet Corporation is under investigation for potential violations of federal securities laws following a defect in its Omnipod 5 product that could lead to serious medical emergencies [1][3]. Group 1: Company Performance and Statements - During the February 18 earnings call, Insulet's executives highlighted strong clinical evidence and real-world outcomes that bolstered confidence among prescribers and patients, with Omnipod 5 being described as the "favorite pump" for both type-1 and type-2 users in 2025 [2]. - CFO Flavia Pease reported that U.S. revenue growth exceeded the high end of the company's guidance range, driven by continued demand for Omnipod 5 among type 1 and type 2 customers [2]. Group 2: Product Issues - A March 12 filing disclosed a defect in Omnipod 5 Pods, specifically insulin leakage that could result in diabetic ketoacidosis, a serious medical emergency [3]. - The statements made by Insulet's executives on February 18 regarding the reliability of Omnipod and patient confidence did not mention any product-quality issues or potential recalls [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims on behalf of investors who suffered significant losses in Helen of Troy Limited following the company's disappointing financial results for Q2 of fiscal 2026 [2][3][4]. Financial Performance - On October 9, 2025, Helen of Troy reported a year-over-year decline of approximately 8.9% in consolidated net sales, totaling around $431.8 million [3][5]. - The company reported a GAAP diluted loss per share of $13.44, influenced by significant charges, while the adjusted diluted earnings per share were approximately $0.59, a substantial decrease from $1.21 in the prior-year period [3][5]. Stock Market Reaction - Following the financial results announcement, Helen of Troy's common stock experienced a sharp decline, falling by $6.90 per share, or approximately 25.0%, closing at $20.71 per share on October 9, 2025 [4][5].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Wealthfront Stock or Options To Contact Him Directly At 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]New York, New York--(Newsfile Corp. - March 20, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Wealthfront Corporation ("Wealthfront" or the "Company") (NASDAQ: WLTH).Far ...

Core Insights - Avis Budget Group reported an adjusted EBITDA growth of 11% for Q4 2025, but under GAAP, the company posted a significant net loss of $856 million [1] - The previous CEO projected that Avis would generate no less than $1 billion of adjusted EBITDA in 2025, but the actual full-year adjusted EBITDA was only $748 million, missing the forecast by approximately $150 million [2] Financial Performance - Adjusted EBITDA for Q4 2025 increased by 11% [1] - GAAP results indicated a net loss of $856 million [1] - Full-year adjusted EBITDA was reported at $748 million, falling short of the $1 billion target [2] Leadership Changes - The company transitioned from then-CEO Joseph Ferraro to new CEO Brian Choi, who reaffirmed the $1 billion adjusted EBITDA target during the Q3 2025 earnings call [2]

Core Insights - Grocery Outlet Holding Corp. is under investigation for potential violations of federal securities laws, as announced by Levi & Korsinsky [1] - The company has revised its FY2025 comparable-store sales outlook to a range of 0.6%-0.9%, a decrease from the previous range of 0.6%-1.2% [2] - Plans to close 36 under-performing stores, representing approximately 6% of the total store base, were announced months later, which were not mentioned during the Q3 2025 earnings call [3] - The FY2026 guidance provided in the same earnings release was significantly below analyst expectations [3] Company Performance - Management expressed confidence in the outlook for gross margin, adjusted EBITDA, and adjusted EPS despite the lowered sales outlook [2] - The closure of stores and the subsequent guidance indicate potential challenges in maintaining growth and profitability [3]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Wealthfront Corporation due to significant stock losses following disappointing earnings and investor concerns about the company's strategic exposures [4][5]. Group 1: Company Performance - Wealthfront Corporation's shares declined sharply after its first post-IPO earnings release, attributed to disappointing asset flow figures and concerns regarding its mortgage business [5]. - The company reported softer net inflows recently, indicating a slowdown in client acquisitions and cash management balances compared to previous periods [5]. - Since its IPO on December 12, 2025, at $14.00 per share, Wealthfront's stock has fallen by $3.74, or 26.71%, closing at $10.26 on January 14, 2026 [6]. Group 2: Investor Concerns - Heightened market scrutiny over the CEO's ownership stake in a banking partner, which is central to Wealthfront's mortgage initiative, has contributed to investor uncertainty [5]. - Speculation around potential conflicts of interest and long-term integration risks has emerged, further fueling investor concerns [5].